Two doses of the Pfizer shot generated a “strong immune response” in kids aged five to 11 similar to that of vaccinated 16 to 25 year olds, the companies said.
Pfizer Prepares To Seek U.S., EU Approval After Study Shows Vaccine Is Safe For Five To 11-Year-Olds
